Search research articles
Contact Us
Filters
Showing results (41-50 of 52) with videos related to
Page
of 6
Sort By:
Journal of Chemotherapy (Florence, Italy)
|
March 20, 2009
The significance of Chlamydia trachomatis in urethritis and prostatitis - differences in therapeutic approach - Croatian experience
Visnja Skerk, L Markovinovic, S Zekan, et al.
Journal of Chemotherapy (Florence, Italy)
|
August 31, 2004
Azithromycin: 4.5- or 6.0-gram dose in the treatment of patients with chronic prostatitis caused by Chlamydia trachomatis--a randomized study
Visnja Skerk, I Krhen, M Lisić, et al.
European Journal of Neurology
|
May 15, 2004
Guidelines for the diagnosis and management of neurological complications of HIV infection
P Portegies, L Solod, P Cinque, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
November 12, 2005
European recommendations for the management of healthcare workers occupationally exposed to hepatitis B virus and hepatitis C virus
V Puro, G De Carli, S Cicalini, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
December 7, 2017
European recommendations for the management of healthcare workers occupationally exposed to hepatitis B virus and hepatitis C virus
V Puro, G De Carli, S Cicalini, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
May 16, 2020
HIV care in times of the COVID-19 crisis - Where are we now in Central and Eastern Europe?
J D Kowalska, A Skrzat-Klapaczyńska, D Bursa, et al.
HIV Medicine
|
October 6, 2020
Where are we with pre-exposure prophylaxis use in Central and Eastern Europe? Data from the Euroguidelines in Central and Eastern Europe (ECEE) Network Group
T Balayan, J Begovac, A Skrzat-Klapaczyńska, et al.
The Journal of Antimicrobial Chemotherapy
|
March 6, 2015
Efficacy of tenofovir and efavirenz in combination with lamivudine or emtricitabine in antiretroviral-naive patients in Europe
J E Swartz, L Vandekerckhove, H Ammerlaan, et al.
HIV Medicine
|
June 27, 2020
Treatment outcomes of integrase inhibitors, boosted protease inhibitors and nonnucleoside reverse transcriptase inhibitors in antiretroviral-naïve persons starting treatment
A Mocroft, B Neesgard, R Zangerle, et al.
HIV Medicine
|
October 25, 2019
The EuroSIDA study: 25 years of scientific achievements
K Laut, O Kirk, J Rockstroh, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 52) with videos related to
Sort By:
Page
of 6
Journal of Chemotherapy (Florence, Italy)
|
March 20, 2009
The significance of Chlamydia trachomatis in urethritis and prostatitis - differences in therapeutic approach - Croatian experience
Visnja Skerk, L Markovinovic, S Zekan, et al.
Journal of Chemotherapy (Florence, Italy)
|
August 31, 2004
Azithromycin: 4.5- or 6.0-gram dose in the treatment of patients with chronic prostatitis caused by Chlamydia trachomatis--a randomized study
Visnja Skerk, I Krhen, M Lisić, et al.
European Journal of Neurology
|
May 15, 2004
Guidelines for the diagnosis and management of neurological complications of HIV infection
P Portegies, L Solod, P Cinque, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
November 12, 2005
European recommendations for the management of healthcare workers occupationally exposed to hepatitis B virus and hepatitis C virus
V Puro, G De Carli, S Cicalini, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
December 7, 2017
European recommendations for the management of healthcare workers occupationally exposed to hepatitis B virus and hepatitis C virus
V Puro, G De Carli, S Cicalini, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
May 16, 2020
HIV care in times of the COVID-19 crisis - Where are we now in Central and Eastern Europe?
J D Kowalska, A Skrzat-Klapaczyńska, D Bursa, et al.
HIV Medicine
|
October 6, 2020
Where are we with pre-exposure prophylaxis use in Central and Eastern Europe? Data from the Euroguidelines in Central and Eastern Europe (ECEE) Network Group
T Balayan, J Begovac, A Skrzat-Klapaczyńska, et al.
The Journal of Antimicrobial Chemotherapy
|
March 6, 2015
Efficacy of tenofovir and efavirenz in combination with lamivudine or emtricitabine in antiretroviral-naive patients in Europe
J E Swartz, L Vandekerckhove, H Ammerlaan, et al.
HIV Medicine
|
June 27, 2020
Treatment outcomes of integrase inhibitors, boosted protease inhibitors and nonnucleoside reverse transcriptase inhibitors in antiretroviral-naïve persons starting treatment
A Mocroft, B Neesgard, R Zangerle, et al.
HIV Medicine
|
October 25, 2019
The EuroSIDA study: 25 years of scientific achievements
K Laut, O Kirk, J Rockstroh, et al.
Page
of 6